Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
The application of precision medicine in diagnosing familial Mediterranean fever.
Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.
Making the Case for Accelerated Withdrawal of Aducanumab.
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes. J Alzheimers Dis. 2023; 94(2):497-507.
View in:
PubMed
subject areas
Alzheimer Disease
Amyloid beta-Peptides
Amyloidogenic Proteins
Antibodies, Monoclonal
Humans
United States
authors with profiles
George Perry